Uptown Research Institute Logo Banner

MDD Study – Outpatient

About the Study

Are you currently experiencing a depressive episode?

This is a study to evaluate the efficacy of a new medication called SAGE-217 when taken alone with one of the following antidepressants: Zoloft, Lexapro, Celexa, Cymbalta, or Effexor. You do not have to currently be taking any anti-depressant to participate in this study. Study sponsored by Sage Therapeutics.

Length of Study: Up to 70 days 

Eligibility 

You may be eligible to participate in this study if you:

  • are between the ages of 18 – 64 years old
  • have been diagnosed with major depressive disorder
  • are experiencing a depressive episode
  • are willing to take either Zoloft, Lexapro, Cymbalta, OR Effexor along with SAGE-217, the study medication  

If chosen for this study, you will be compensated for every study visit that you complete and we can provide transportation if needed.

If you are interested in participating in this clinical trial, please call our friendly staff at 773-989-8313 ext. 117 today. You can also fill out the contact form below.

Schizophrenia Study Form

Share this post on Facebook